Literature DB >> 23574502

The validity and responsiveness of the EQ-5D measure of health-related quality of life in an adolescent population with persistent major depression.

Sarah Byford1.   

Abstract

BACKGROUND: Despite a preference for economic evaluations to measure outcomes in terms of quality-adjusted life years, generic measures of outcome are rarely used in mental health research involving young people. AIMS: To explore the validity and responsiveness of the EQ-5D measure of health-related quality of life in adolescents with major depression.
METHOD: Data came from a clinical trial involving adolescents with persistent major depression (n =  199). Construct validity was tested using socio-demographic constructs and baseline clinical outcome scores. To assess convergent validity, correlation between EQ-5D and clinical outcome scores was tested. To assess responsiveness, the mean change in EQ-5D scores of participants categorised as improved versus not improved on clinical outcome measures was tested.
RESULTS: Significant differences in mean EQ-5D score were found for co-morbidity and three of four severity measures but not gender, age, treatment history or suicide attempts. Mean EQ-5D scores were significantly correlated with all clinical outcome measures, although relationships were moderate or weak. A change in mean EQ-5D score was significantly related to clinical assessments of improvement on all outcome measures.
CONCLUSIONS: Results provide initial evidence to support the relevance of the EQ-5D in adolescents with major depression, but this evidence is weak. Replication studies are needed to assess the generalisability of these findings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23574502     DOI: 10.3109/09638237.2013.779366

Source DB:  PubMed          Journal:  J Ment Health        ISSN: 0963-8237


  12 in total

1.  Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): a pragmatic, randomised controlled, superiority trial.

Authors:  Peter Fonagy; Stephen Butler; David Cottrell; Stephen Scott; Stephen Pilling; Ivan Eisler; Peter Fuggle; Abdullah Kraam; Sarah Byford; James Wason; Rachel Ellison; Elizabeth Simes; Poushali Ganguli; Elizabeth Allison; Ian M Goodyer
Journal:  Lancet Psychiatry       Date:  2018-01-05       Impact factor: 27.083

2.  Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression.

Authors:  John F Dickerson; David H Feeny; Gregory N Clarke; Alex L MacMillan; Frances L Lynch
Journal:  Qual Life Res       Date:  2017-11-17       Impact factor: 4.147

3.  Preferred intensity exercise for adolescents receiving treatment for depression: a pragmatic randomised controlled trial.

Authors:  Tim Carter; Boliang Guo; David Turner; Ioannis Morres; Elizabeth Khalil; Emily Brighton; Marie Armstrong; Patrick Callaghan
Journal:  BMC Psychiatry       Date:  2015-10-14       Impact factor: 3.630

4.  Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial.

Authors:  Ian M Goodyer; Shirley Reynolds; Barbara Barrett; Sarah Byford; Bernadka Dubicka; Jonathan Hill; Fiona Holland; Raphael Kelvin; Nick Midgley; Chris Roberts; Rob Senior; Mary Target; Barry Widmer; Paul Wilkinson; Peter Fonagy
Journal:  Lancet Psychiatry       Date:  2016-12-01       Impact factor: 27.083

5.  Cost-effectiveness of a preferred intensity exercise programme for young people with depression compared with treatment as usual: an economic evaluation alongside a clinical trial in the UK.

Authors:  David Turner; Tim Carter; Tracey Sach; Boliang Guo; Patrick Callaghan
Journal:  BMJ Open       Date:  2017-11-26       Impact factor: 2.692

6.  The effectiveness and cost-effectiveness of a mindfulness training programme in schools compared with normal school provision (MYRIAD): study protocol for a randomised controlled trial.

Authors:  Willem Kuyken; Elizabeth Nuthall; Sarah Byford; Catherine Crane; Tim Dalgleish; Tamsin Ford; Mark T Greenberg; Obioha C Ukoumunne; Russell M Viner; J Mark G Williams
Journal:  Trials       Date:  2017-04-26       Impact factor: 2.279

7.  EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.

Authors:  Mimmi Åström; Sonja Krig; Sara Ryding; Neil Cleland; Ola Rolfson; Kristina Burström
Journal:  Health Qual Life Outcomes       Date:  2020-06-03       Impact factor: 3.186

Review 8.  Assessing quality of life in psychosocial and mental health disorders in children: a comprehensive overview and appraisal of generic health related quality of life measures.

Authors:  Jochen O Mierau; Daphne Kann-Weedage; Pieter J Hoekstra; Lisan Spiegelaar; Danielle E M C Jansen; Karin M Vermeulen; Sijmen A Reijneveld; Barbara J van den Hoofdakker; Erik Buskens; M Elske van den Akker-van Marle; Carmen D Dirksen; Annabeth P Groenman
Journal:  BMC Pediatr       Date:  2020-07-03       Impact factor: 2.125

9.  Health related quality of life for young people receiving dialectical behaviour therapy (DBT): a routine outcome-monitoring pilot.

Authors:  M Swales; R A B Hibbs; L Bryning; R P Hastings
Journal:  Springerplus       Date:  2016-07-20

10.  Depression: an exploratory parallel-group randomised controlled trial of Antenatal guided self help for WomeN (DAWN): study protocol for a randomised controlled trial.

Authors:  Kylee Trevillion; Jill Domoney; Andrew Pickles; Debra Bick; Sarah Byford; Margaret Heslin; Jeannette Milgrom; Rachel Mycroft; Carmine Pariante; Elizabeth Ryan; Myra Hunter; Louise Michele Howard
Journal:  Trials       Date:  2016-10-18       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.